Grant Number:	5R01CA251758-04 Interpret this number
Primary Investigator:	Aldrich, Melinda
Organization:	Vanderbilt University Medical Center
Project Title:	Addressing Racial Disparities in Lung Cancer Screening
Fiscal Year:	2024

PROJECT SUMMARY/ABSTRACT Screening promotes early detection of cancer to decrease mortality. Unfortunately, significant racial disparities exist in lung cancer screening. Recently published findings by our team show that under current national screening guidelines African Americans have reduced eligibility for lung cancer screening compared to whites. These screening guidelines are based on a combination of age and smoking pack-year criteria derived from a national lung screening trial that was primarily (91%) white. Importantly, smoking behaviors and baseline risks for lung cancer differ greatly between African Americans and whites. Because of this, a risk-based screening strategy may provide a more equitable assessment of eligibility than current screening guidelines. However, the development of personalized risk prediction models for lung cancer in African Americans has been limited. To address this gap and to improve equity in screening eligibility, we propose building a personalized prediction tool using the combined data from three large-scale population-based prospective cohorts with substantial African American representation. The combined cohorts have over 336,000 individuals (44% African American) and 9,132 incident lung cancer cases from across the United States. We propose the following three aims: 1) construct a well-calibrated natural-history model of lung cancer risk for screening in African Americans, 2) evaluate lung cancer screening strategies by simulation and identify sub-populations who would benefit from screening, accounting for comorbidities and false-positives, and 3) develop a web-based decision aid for screening that is culturally appropriate. We will employ innovative machine learning techniques and state-of-the- art statistical methods to build a well-calibrated lung cancer prediction model for African Americans. Careful examination will identify sub-populations (such as women, low socioeconomic status, rural, age groups, etc.) that will benefit from screening. A key innovative aspect of this proposal is its community-engaged approach and partnership with a Community Advisory Board, both of which will help translate our empirical findings into the design of a patient-oriented decision aid. This project is relevant to the mission of the National Cancer Institute since it focuses on establishing equity in lung cancer screening eligibility. Our findings will have sustained impact on precision health and motivate improved clinical strategies for the early detection of lung cancer for African Americans.




Germline prediction of immune checkpoint inhibitor discontinuation for immune-related adverse events.
Authors: Middha P. , Thummalapalli R. , Quandt Z. , Balaratnam K. , Cardenas E. , Falcon C.J. , Princess Margaret Lung Group , Gubens M.A. , Huntsman S. , Khan K. , et al. .
Source: Medrxiv : The Preprint Server For Health Sciences, 2024-06-11 00:00:00.0; , .
EPub date: 2024-06-11 00:00:00.0.
PMID: 38947092
Related Citations

Interaction between Continuous Pack-Years Smoked and Polygenic Risk Score on Lung Cancer Risk: Prospective Results from the Framingham Heart Study.
Authors: Duncan M.S. , Diaz-Zabala H. , Jaworski J. , Tindle H.A. , Greevy R.A. , Lipworth L. , Hung R.J. , Freiberg M.S. , Aldrich M.C. .
Source: Cancer Epidemiology, Biomarkers & Prevention : A Publication Of The American Association For Cancer Research, Cosponsored By The American Society Of Preventive Oncology, 2024-04-03 00:00:00.0; 33(4), p. 500-508.
PMID: 38227004
Related Citations

Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis.
Authors: Middha P. , Thummalapalli R. , Betti M.J. , Yao L. , Quandt Z. , Balaratnam K. , Bejan C.A. , Cardenas E. , Falcon C.J. , Faleck D.M. , et al. .
Source: Nature Communications, 2024-03-26 00:00:00.0; 15(1), p. 2568.
EPub date: 2024-03-26 00:00:00.0.
PMID: 38531883
Related Citations

Minimum entropy framework identifies a novel class of genomic functional elements and reveals regulatory mechanisms at human disease loci.
Authors: Betti M.J. , Aldrich M.C. , Gamazon E.R. .
Source: Biorxiv : The Preprint Server For Biology, 2023-06-12 00:00:00.0; , .
EPub date: 2023-06-12 00:00:00.0.
PMID: 37398170
Related Citations

Genetic prediction of colitis in non-small cell lung cancer patients on immune checkpoint inhibitor therapy.
Authors: Middha P. , Thummalapalli R. , Betti M.J. , Quandt Z. , Balaratnam K. , Cardenas E. , Falcon C.J. , Faleck D.M. , Princess Margaret Lung Group , Gubens M.A. , et al. .
Source: Medrxiv : The Preprint Server For Health Sciences, 2023-05-16 00:00:00.0; , .
EPub date: 2023-05-16 00:00:00.0.
PMID: 37292751
Related Citations

Sex modifies the effect of genetic risk scores for polycystic ovary syndrome on metabolic phenotypes.
Authors: Actkins K.V. , Jean-Pierre G. , Aldrich M.C. , Velez Edwards D.R. , Davis L.K. .
Source: Plos Genetics, 2023 May; 19(5), p. e1010764.
EPub date: 2023-05-31 00:00:00.0.
PMID: 37256887
Related Citations

Racial Disparities in Lung Cancer Stage of Diagnosis Among Adults Living in the Southeastern United States.
Authors: Richmond J. , Murray M.H. , Milder C.M. , Blume J.D. , Aldrich M.C. .
Source: Chest, 2022-11-24 00:00:00.0; , .
EPub date: 2022-11-24 00:00:00.0.
PMID: 36435265
Related Citations

Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program.
Authors: Robbins H.A. , Alcala K. , Moez E.K. , Guida F. , Thomas S. , Zahed H. , Warkentin M.T. , Smith-Byrne K. , Brhane Y. , Muller D. , et al. .
Source: Annals Of Epidemiology, 2022-10-29 00:00:00.0; 77, p. 1-12.
EPub date: 2022-10-29 00:00:00.0.
PMID: 36404465
Related Citations

Psychosocial impact of COVID-19 among adults in the southeastern United States.
Authors: Richmond J. , Sanderson M. , Shrubsole M.J. , Holowatyj A.N. , Schlundt D.G. , Aldrich M.C. .
Source: Preventive Medicine, 2022-08-11 00:00:00.0; , p. 107191.
EPub date: 2022-08-11 00:00:00.0.
PMID: 35964774
Related Citations

Inclusion of Smoking Data in Cardiovascular Disease Risk Estimation.
Authors: Duncan M.S. , Greevy R.A. , Tindle H.A. , Vasan R.S. , Lipworth L. , Aldrich M.C. , Lloyd-Jones D.M. , Freiberg M.S. .
Source: Jama Cardiology, 2022-02-01 00:00:00.0; 7(2), p. 195-203.
PMID: 34878493
Related Citations

Disruption of medical care among individuals in the southeastern United States during the COVID-19 pandemic.
Authors: Ni B. , Gettler E. , Stern R. , Munro H.M. , Steinwandel M. , Aldrich M.C. , Friedman D.L. , Sanderson M. , Schlundt D. , Aronoff D.M. , et al. .
Source: Journal Of Public Health Research, 2021-09-24 00:00:00.0; , .
EPub date: 2021-09-24 00:00:00.0.
PMID: 34558253
Related Citations

Immunotherapy-Mediated Thyroid Dysfunction: Genetic Risk and Impact on Outcomes with PD-1 Blockade in Non-Small Cell Lung Cancer.
Authors: Luo J. , Martucci V.L. , Quandt Z. , Groha S. , Murray M.H. , Lovly C.M. , Rizvi H. , Egger J.V. , Plodkowski A.J. , Abu-Akeel M. , et al. .
Source: Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research, 2021-09-15 00:00:00.0; 27(18), p. 5131-5140.
EPub date: 2021-07-08 00:00:00.0.
PMID: 34244291
Related Citations

A Call to Action: Dismantling Racial Injustices in Preclinical Research and Clinical Care of Black Patients Living with Small Cell Lung Cancer.
Authors: Thomas P.L. , Madubata C.J. , Aldrich M.C. , Lee M.M. , Owonikoko T.K. , Minna J.D. , Rudin C.M. , Sage J. , Lovly C.M. .
Source: Cancer Discovery, 2021 02; 11(2), p. 240-244.
EPub date: 2020-12-14 00:00:00.0.
PMID: 33318034
Related Citations